Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

196 results about "Immunopotentiator" patented technology

A drug that stimulates the immune system

Synergist of feed additive and application of synergist in improving growth performance and anti-stress capability of litopenaeus vannamei larvae

The invention discloses a synergist of a feed additive and application of the synergist to improvement of growth performance and anti-stress ability of litopenaeus vannamei larvae. The synergist comprises an immunopotentiator, composite vitamins and composite mineral salt, the feed additive specifically comprises mannan oligosaccharide, haematococcus pluvialis, chlorogenic acid, vitamin C phosphate, vitamin E, inositol, monocalcium phosphate, selenium yeast, zinc glycinate and manganese glycinate, and the feed additive comprises methionine, lysine, threonine, arginine, taurine and zeolite powder. After the synergist and the feed additive are uniformly mixed, the mixture is added into a basal feed, and the prepared compound feed for the juvenile litopenaeus vannamei can improve the growth speed and survival rate of the litopenaeus vannamei and improve the stress capability of resisting acute hypoxia and low salt stress. In addition, the prepared compound feed for the juvenile litopenaeus vannamei can effectively meet the nutritional requirements of the litopenaeus vannamei and can be applied to culture production of the litopenaeus vannamei on a large scale.
Owner:GUANGDONG OCEAN UNIVERSITY

Paenibacillus kribbensis exopolysaccharide and application thereof in prevention and control of iridovirus disease of micropterus salmoides

The invention discloses paenibacillus kribbensis exopolysaccharide and application thereof in prevention and control of iridovirus diseases of micropterus salmoides. The invention provides a paenibacillus kribbensis exopolysaccharide. The paenibacillus kribbensis exopolysaccharide is prepared from a fermentation product of a paenibacillus kribbensis space mutation delta PS04-17 strain. As a fish feed additive, the paenibacillus kribbensis exopolysaccharide has better in-vivo safety, has a promoting effect on the growth of the largemouth bass, and can promote the growth and weight gain of the largemouth bass and reduce the feed coefficient of the largemouth bass. Meanwhile, as a drug for resisting LMBV virus infection, the compound can inhibit expression of viruses in target tissues, alleviate virus-induced fish body target tissue structure damage and reduce the death rate caused by virus infection. Besides, the paenibacillus kribbensis exopolysaccharide serving as a disease-resistant immunopotentiator can maintain intestinal health of the micropterus salmoides, is simple to prepare, low in cost and easy to obtain in quantity, and provides more products and methods for prevention and control of the iridovirus disease of the micropterus salmoides.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Small molecule immunopotentiator conjugates of NFKB activators as adjuvants with enhanced efficacy and reduced toxicity

The present disclosure concerns immunomodulatory compositions and methods of use for enhancing response to an antigen (e.g., in a vaccine), an immunotherapy (e.g., a cancer immunotherapy), or other immune stimulation. The disclosure describes immunomodulators having reduced toxicity and improved immune response compared with existing adjuvants. Further disclosed are methods for improving an immune response to a vaccine antigen, cancer immunotherapeutic, or other immune stimulating agent. The disclosure describes dimeric and polymeric immunomodulators comprising one or more pattern recognition receptor (PRR) agonist moieties and one or more NF-κB inhibitor moieties.
Owner:UNIVERSITY OF CHICAGO

Application of bleomycin as immunopotentiator

The invention belongs to the technical field of biological medicines, and particularly relates to application of bleomycin or bleomycin analogues in preparation of an immunopotentiator. The invention also provides a pharmaceutical composition and application of the pharmaceutical composition in preparation of drugs for treating and / or preventing cancers. The pharmaceutical composition comprises bleomycin, bleomycin analogues or a combination thereof and an anti-tumor immunotherapeutic agent.
Owner:CHONGQING MEDICAL UNIVERSITY

Spina date seed peptide zinc chelate as well as preparation method and application thereof

The invention belongs to the technical field of food processing, and provides a spina date seed peptide zinc chelate as well as a preparation method and application thereof. The spina date seed peptide zinc chelate is stable in performance and high in absorption efficiency. The preparation method comprises the following steps: degreasing a spina date seed medicinal material; preparing spina date seed protein; preparing spina date seed polypeptide; carrying out chelation reaction on the spina date seed polypeptide and zinc sulfate heptahydrate; and separating a chelation reaction product. The spina date seed peptide zinc chelate prepared by the invention can be directly used as a natural immunopotentiator to improve the immunity of a human body. The method has the advantages of short production cycle, low cost, no pollution to the environment, abundant nutrition, high protein content, small particle size, high safety and high utilization rate of effective components, and can be widely applied to the fields of foods, medicines and health care.
Owner:SHANXI UNIV OF CHINESE MEDICINE

RNA cancer vaccines

The disclosure relates to cancer ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines. In particular, the disclosure relates to concatemeric mRNA cancer vaccines encoding several cancer epitopes on a single mRNA construct, i.e. poly-epitope mRNA constructs or poly-neo-epitope constructs. The disclosure further relates to p53 and KRAS mutations, as well as incorporation of immune enhancers such as STING, e.g. mRNA constructs further encoding an immune stimulator or adjuvant. The disclosure further relates to inclusion of universal T cell epitopes, such as tetanus or diphtheria toxins to elicit an enhanced immune response.
Owner:MODERNATX INC

Fusion gene of grass carp NPM1a and II type reovirus VP38, recombinant protein, composition and application

The invention relates to the technical field of aquaculture fish vaccines, in particular to a fusion gene of grass carp NPM1a and II type reovirus VP38, recombinant protein, a composition and application. The nucleotide sequence of the fusion gene is as shown in SEQ ID NO: 1. The fusion gene is obtained by connecting grass carp NPM1a and II type reovirus VP38 through a linker sequence, a BamH restriction enzyme cutting site is added to the 5'end of the fusion sequence, and an XhoI restriction enzyme cutting site is added to the 3 'end of the fusion sequence; the sequence of the linker is as shown in SEQ ID NO: 2. The subunit vaccine of the fusion protein of the grass carp NPM1a and the II type reovirus VP38 is prepared, and indole-3-lactic acid is used as an immunopotentiator in a combined manner, so that the technical bottlenecks of low protection rate, poor intestinal mucosal barrier repairability and the like of the existing vaccine are overcome.
Owner:HUNAN NORMAL UNIVERSITY

Dendrobium huoshanense polysaccharide nanoemulsion immunologic adjuvant and preparation method thereof

The invention discloses a dendrobium huoshanense polysaccharide nanoemulsion immunologic adjuvant and a preparation method thereof. The dendrobium huoshanense polysaccharide nanoemulsion immunologic adjuvant is prepared from the following raw materials in percentage by mass: 0.1%-2.0% of dendrobium huoshanense polysaccharide, 20%-30% of a surfactant, 5%-10% of a cosurfactant, 5%-10% of an oil phase and the balance of deionized water. The preparation method of the nano-emulsion is simple and easy to implement, equipment is easy to control, the cost is low, and the obtained nano-emulsion is small in droplet particle size, high in stability and capable of improving the spleen lymphocyte proliferation activity of immunocompromised mice. The nanoemulsion can significantly improve the immunomodulatory activity of dendrobium huoshanense polysaccharide, and has the potential of developing immunopotentiators, thereby promoting the development and utilization of traditional Chinese medicine resources and active components thereof.
Owner:WEST ANHUI UNIV

Immunogenic composition for preventing neisseria meningitidis

The composition is prepared from group B meningococcus NHBA recombinant protein, fHbp (V1-V1) recombinant protein and fHbp (V2-V3) recombinant protein obtained through artificial modification, or three corresponding recombinant proteins obtained by further adding P4 signal peptide on the basis of the group B meningococcus NHBA recombinant protein, the fHbp (V1-V1) recombinant protein and the fHbp (V2-V3) recombinant protein, and animal experiments prove that the composition has good immunogenicity and can be used for preparing the immunopotentiator. The compound can be used for preparing vaccines for preventing group B meningococcus.
Owner:FOSUN ADGENVAX BIOTECHONOLOGY CO LTD

Oil-in-water type veterinary adjuvant and preparation method thereof

The invention belongs to the technical field of animal immunopotentiators, and particularly relates to an oil-in-water type veterinary adjuvant and a preparation method thereof. The oil-in-water type veterinary adjuvant comprises white oil, span 80, Tween 80, PEG400, astragalus polysaccharide and a phosphate buffer solution, the astragalus polysaccharide cooperates with a surfactant to activate a TLR4 / NF-kappa B pathway, Th1 / Th2 / Th17 three-way immune response is achieved, the serum IgG and mucous membrane sIgA antibody level is remarkably improved, and the problems that a traditional O / W adjuvant is high in layering rate (smaller than 5%), and the stability of the traditional O / W adjuvant is poor are solved through compound optimization of the HLB value (HLB = 11.5-12.0) of the HLB value of span 80 and Tween 80. And storage at 4 DEG C for 90 days) and poor freeze-thaw stability are solved.
Owner:CHINA AGRI UNIV +2

Immunogenic composition containing adjuvant as well as preparation method and application of immunogenic composition

The invention discloses an immunogenic composition containing an adjuvant as well as a preparation method and application of the immunogenic composition. The immunogenic composition comprises self-assembled gE virus-like nanoparticles, an immunopotentiator, namely, saponin QS-21, and a neutral liposome, the self-assembled gE virus-like nanoparticles are formed by polymerizing and assembling monomers; the monomers include VZV gE, a linker peptide (SGS), and a VZV gI polypeptide containing a Th epitope. The immunogenic composition can be applied to varicella-zoster virus vaccines, and solves the technical problems of weak gE immunogenicity and serious vaccine side reaction in vaccines prepared in the prior art. The immunogenicity of the vaccine is equivalent to that of the Xinanlii, and the use of an immunopotentiator in the vaccine can be reduced, so that the clinical side reaction of the vaccine is lower; in addition, the vaccine can induce a gI specific antibody and gI specific CMI reaction, and the effectiveness of the vaccine can be further improved. In short, the immunogenic composition has good clinical application potential.
Owner:YUNNAN CHANGHE BIOTECHNOLOGY CO LTD

Fungus-diatom synergistic immunopotentiator for stichopus japonicus

The invention relates to a fungus-diatom synergistic immunopotentiator for stichopus japonicus, and belongs to the technical field of microbial engineering and echinoderm immunology. The immunopotentiator is a symbiont microsphere taking yarrowia lipolytica and navicula seminuda as main components; the method comprises the following steps: respectively activating yarrowia lipolytica and navicula seminuda, carrying out expanding culture, resuspending, and adjusting the concentrations of a bacterial solution and algae cells; the preparation method comprises the following steps: adding a navicula seminuda concentrated solution and a yarrowia lipolytica suspension into a triangular flask containing a YPD liquid culture medium, adding selenium-containing fucoidan polysaccharide sulfate accounting for 0.4-1.2% of the total mass of microspheres, carrying out constant-temperature shake culture, filtering by using sterile gauze to obtain microspheres, and flushing by using sterile normal saline to obtain fungus-diatom symbiont microspheres; the yarrowia lipolytica, the navicula seminuda and the selenium-containing fucoidan polysaccharide sulfate in the prepared immunopotentiator are mutually beneficial and have a synergistic effect, and the non-specific immune function of the stichopus japonicus is comprehensively improved by improving the growth index, enhancing the activity of immune enzyme and digestive enzyme and improving the disease resistance.
Owner:LIAONING ACAD OF MARINE FISHERIES SCI (DALIAN INST OF BIOTECHNOLOGY LIAONING ACAD OF AGRI SCI LIAONING MARINE ENVIRONMENT MONITORING STATION)

Composite adjuvant

The invention discloses a composite adjuvant, and belongs to the field of vaccine adjuvants. The main active components of the composite adjuvant are squalene, polysorbate 80 and monophosphoryl ester A, the composite adjuvant is in an oil-in-water emulsion form, nano-scale emulsion droplet particles are uniformly distributed in a water phase, and the system is stable. The invention also discloses a preparation method of the composite adjuvant based on a stirring method. The composite adjuvant comprehensively utilizes the dual characteristics of the oil-in-water emulsion and the immunopotentiator, and can induce a higher level of immunoreaction when being combined with the antigen, so that the composite adjuvant can be used for preparing vaccines and improving the effectiveness of the vaccines.
Owner:FOSUN ADGENVAX BIOTECHONOLOGY CO LTD

Nano platform based on attenuated bacterial outer membrane vesicles and capable of achieving co-delivery of siRNA and adriamycin and preparation method of nano platform

The invention belongs to the technical field of drug co-delivery, and particularly relates to a nano-platform based on attenuated bacterial outer membrane vesicles and capable of achieving co-delivery of siRNA and adriamycin and a preparation method of the nano-platform. The preparation method comprises the following steps: synthesizing an ROS response type cationic polymer PTP; the preparation method comprises the following steps: preparing aptamer-DOX; preparing an ROS (reactive oxygen species) response type positive electric nano core PTP / 47aD; extracting and purifying the [delta] msbB OMVs; synthesizing a target functional unit DSPE-PEG2k-Angiopep-2 (Distearoyl Phosphate Polyethylene Glycol 2k-Angiopep-2); finally, the ROS response type co-delivery nano platform AO (at) PTP / 47aD is prepared and obtained. The co-delivery nano-platform prepared by the invention is relatively small in particle size, uniform in morphology and relatively high in biological safety, and has no obvious damage to various tissues and visceral organs. The glioblastoma immunopotentiator can be used as a general platform for gene delivery, can also be used as an immune activator, is suitable for intravenous injection administration, and can comprehensively overcome immune resistance of glioblastoma.
Owner:FUDAN UNIVERSITY

Culture medium for constructing colorectal cancer peritoneal metastasis micro-tumor cell model and application thereof

ActiveCN120272428ACell dissociation methodsCulture processProtein nogginOncology
The invention discloses a culture medium for constructing a colorectal cancer peritoneal metastasis micro-tumor cell model and application of the culture medium. The invention relates to the technical field of biology, and provides a culture medium for culturing a micro-tumor model for colorectal cancer peritoneal metastasis. The invention discloses a cholera toxin immunopotentiator, which is composed of an antibacterial and antifungal agent three antibody, HEPES, GlutaMax, a human recombinant protein EGF, a human recombinant protein bFGF, a human recombinant protein HGF, a human recombinant protein Noggin, a human recombinant protein R-spondin 1, a human recombinant protein GDNF, SB202190, A83-01, Primocin, N-acetyl-L-cysteine, nicotinamide, an N2 additive, cholera toxin, B27, ITS-X, Y-27632, Galunissertib and a basal culture medium. The culture medium and the culture method disclosed by the invention can effectively improve the culture success rate of colorectal cancer peritoneal metastasis and focus combination.
Owner:WUXI CORNERSTONE MEDICAL TESTING LABORATORY CO LTD

Tatrtaxhyplesin II alpha2 antibacterial peptide from tachypleus tridentatus as well as preparation method and application of Tatrtaxhyplesin II alpha2 antibacterial peptide

PendingCN118955672AEnhanced inhibitory effectstrong growth inhibitory effectAntibacterial agentsPeptide/protein ingredientsShigella spBacillus cereus
The invention relates to the technical field of biology, in particular to a tachyplesin Tatrtaxhyplesin II alpha 2 antibacterial peptide from tachypleus tridentatus as well as a preparation method and application of the tachyplesin Tatrtaxhyplesin II alpha 2 antibacterial peptide from tachypleus tridentatus, and relates to a tachyplesin Tatrtaxhyplesin II alpha 2 antibacterial peptide from tachypleus tridentatus. It is verified that the antibacterial peptide has a good inhibition effect on common pathogenic bacteria of aquaculture, such as escherichia coli, bacillus subtilis, staphylococcus aureus, corynebacterium glutamicum, vibrio alginolyticus, vibrio fluvialis, micrococcus luteus, shigella freundii, bacillus cereus vibrio harveyi, aeromonas hydrophila and / or pseudomonas stutzeri, and meanwhile, the antibacterial peptide has the good inhibition effect on the common pathogenic bacteria of aquaculture. The peptide has a good growth inhibition effect on gastric cancer cells SGC-7901 and / or esophageal cancer cells Eca-109, can be widely applied to the fields of drug research and development and animal breeding immunopotentiators, and is a rare peptide product.
Owner:FOURTH INSTITUTE OF OCEANOGRAPHY MINISTRY OF NATURAL RESOURCES (CHINA ASEAN COUNTRIES JOINT RESEAR

Immunogenic composition containing composite adjuvant as well as preparation method and application of immunogenic composition

The invention discloses an immunogenic composition containing a composite adjuvant as well as a preparation method and application of the immunogenic composition. The immunogenic composition comprises a gE-gI fusion protein, an immunopotentiator, namely, saponin QS-21, and a neutral liposome, the gE-gI fusion protein comprises a VZV gE, a connecting peptide and a VZV gI. The immunogenic composition provided by the invention only contains one immunopotentiator, can be applied to VZV vaccines, and solves the problems of relatively weak gE immunogenicity and relatively large clinical side reaction of the vaccines prepared in the prior art. The immunogenicity of the vaccine is equivalent to that of the Xinanlii, but the vaccine contains fewer immunopotentiators and has lower clinical side effects; in addition, the vaccine can also induce a gI specific antibody and gI specific CMI reaction, which is beneficial to further improvement of the effectiveness of the vaccine. In short, the immunogenic composition has good clinical application potential.
Owner:YUNNAN CHANGHE BIOTECHNOLOGY CO LTD

Composition for enhancing immunity comprising polysaccharide enzyme-treated product or purified fraction thereof

PCT designated stageWO2026135372A1Food shapingBiotechnologyAngelica gigas
The present invention relates to a composition for enhancing immunity, containing, as an active ingredient, a polysaccharide enzyme-treated product derived from a mixed extract of Angelica gigas, Cnidium officinale, and Paeonia lactiflora, or a novel purified polysaccharide fraction thereof. The composition for enhancing immunity according to the present invention, comprising the polysaccharide enzyme-treated product of the mixed extract of Angelica gigas, Cnidium officinale, and Paeonia lactiflora or the novel purified polysaccharide fraction thereof, is composed of specific types and contents of sugars and significantly increases the activity of macrophages, splenocytes, and NK cells upon application thereto, thereby being applicable as an immunopotentiator or a composition for enhancing immunity.
Owner:KOLMAR BNH CO LTD

Chinese herbal medicine immunopotentiator for special fur economic animals as well as preparation method and application of Chinese herbal medicine immunopotentiator

The invention discloses a Chinese herbal medicine immunopotentiator for special fur economic animals as well as a preparation method and application of the Chinese herbal medicine immunopotentiator. Belongs to the technical field of traditional Chinese medicine preparations. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 2-4 parts of echinacea purpurea, 2-4 parts of bighead atractylodes rhizome, 2-4 parts of Chinese yam, 1-2 parts of medlar and 1-2 parts of codonopsis pilosula. The raw material medicines are subjected to crushing, burdening, water boiling extraction, concentration and packaging to prepare the medicine. The Chinese herbal medicine immunopotentiator for the special fur economic animals has good effects of enhancing the disease resistance and disease prevention capability of racoon dog and improving the immunity.
Owner:HEBEI NORMAL UNIVERSITY OF SCIENCE & TECHNOLOGY

Long oyster CgVg functional domain DUF1943 and VWD recombinant protein and its application

The present invention belongs to the field of molecular biology technology, and in particular relates to a recombinant protein of the CgVg functional domain DUF1943 and VWD of the long oyster, as well as a preparation method and application thereof. The amino acid sequence of the recombinant protein of the CgVg functional domain DUF1943 of the long oyster is shown in SEQ ID NO.1. The amino acid sequence of the recombinant protein of the CgVg functional domain VWD of the long oyster is shown in SEQ ID NO.2. The recombinant proteins of the CgVg functional domain DUF1943 and VWD of the long oyster obtained by the present invention have a wide range of binding activity against microorganisms, among which the DUF1943 recombinant protein has the activity of agglutinating bacteria and fungi, and the VWD recombinant protein has a broad spectrum of activity in inhibiting bacterial growth, and can be applied to the research and development of antibacterial drugs, immunopotentiators and feed additives for marine organisms.
Owner:DALIAN OCEAN UNIV

Newcastle disease DNA vaccine nano composite adjuvant as well as preparation method and application thereof

The invention relates to the technical field of vaccine adjuvants, in particular to a Newcastle disease DNA vaccine nano-composite adjuvant and a preparation method and application thereof.The composite adjuvant comprises an agent A and an agent B. The agent A is an aluminum-magnesium hydrotalcite nano-particle solution, the agent B is an okra polysaccharide RPS-1 solution, and the agent A is prepared by taking magnesium chloride hexahydrate and aluminum chloride hexahydrate as raw materials through a one-step method. The agent B is prepared by taking fresh okra fruits as raw materials and adopting a water extraction and alcohol precipitation method; the composite adjuvant is used as a loading agent to be matched with a Newcastle disease nucleic acid vaccine for preventing and treating Newcastle disease. According to the present invention, the aluminum-magnesium hydrotalcite and the okra polysaccharide RPS-1 are combined in the composite form, such that the antibody level and the thymus index of the chicken can be improved, and the product can be adopted as the immunopotentiator of the Newcastle disease DNA vaccine, can be adopted as the carrier to protect the DNA vaccine from degradation, can increase the immunocompetence of the DNA vaccine, and can enhance the animal immune function; the method has a certain popularization value in prevention and control of animal infectious diseases.
Owner:HAINAN UNIV

Immune synergist, enhanced NK cell preparation, preparation method and application

The invention relates to the technical field of biological medicine, in particular to an immune synergist, an enhanced NK cell preparation, a preparation method and application. The immune synergist is hirudin, and the concentration of the hirudin is 10-40 [mu] g / ml. The enhanced NK cell preparation is prepared by the preparation method. According to the preparation method, the enhanced NK cell preparation is obtained after NK cells which are amplified in vitro for 14 days are pretreated by adopting the immune synergist. The application comprises an application of the immune synergist in up-regulation of expression of NK cell granzyme B and an application of the immune synergist in preparation of an NK cell preparation for inhibiting breast cancer cell activity. The expression level of granzyme B of the NK cells can be safely and economically improved, and the in-vitro killing activity of the NK cells to breast cancer cells is remarkably enhanced.
Owner:HUNAN HUAKE BIOTECHNOLOGY CO LTD

Application of parabacteroides dielsii and / or parabacteroides gold in preparation of immunopotentiator of vaccine

The invention relates to the technical field of immunization. The invention discloses parabacteroides dieldrii and parabacteroides goldsteinii, an application of the parabacteroides dieldrii and / or the parabacteroides goldsteinii in preparation of an immunopotentiator of a vaccine, and the immunopotentiator of the vaccine, and particularly discloses the parabacteroides dieldrii and the parabacteroides goldsteinii, the application of the parabacteroides dieldrii and / or the parabacteroides goldsteinii in preparation of the immunopotentiator of the vaccine. The parabacteroides dieldrii and / or the parabacteroides gold can be used as an immunopotentiator, can activate immunity, enhance antibody titer and shorten antibody generation reaction time, and can remarkably promote proliferation of B cells, plasma cells and memory B cell subgroups in a hair growth center.
Owner:TSINGHUA UNIVERSITY

Method for producing immunoactivator for pets

To provide a method for producing an immunoactivator for pets, which enables efficient and low-cost production from bamboo as the starting material.SOLUTION: A method for producing an immunoactivator for pets comprises: a pulverization step of pulverizing bamboo to provide bamboo powder; a fermentation step of fermenting the bamboo powder derived from the pulverization step by means of bamboo-derived lactic acid bacteria to provide a fermented bamboo product; an extraction step of subjecting the fermented bamboo product derived from the fermentation step to hot water extraction to provide a bamboo fermentation extract; a filtration step of filtering the bamboo fermentation extract derived from the extraction step; and a drying step of drying the residue formed in the filtration step.SELECTED DRAWING: Figure 1
Owner:SANCHO CO LTD

Immunopotentiator crude product precipitation separation device

The invention relates to the technical field of precipitation separation equipment, and discloses an immunopotentiator crude product precipitation separation device which comprises a precipitation tank used for precipitation separation of an immunopotentiator; the sealed tank body is used for being in sealed butt joint with the top of the precipitation tank body, and a feeding opening is formed in the top of the sealed tank body; the cleaning mechanism is used for covering the top of the precipitation tank body and cleaning the interior of the precipitation tank body; the lifting and rotating mechanism is used for switching butt joint of the sealing tank body or the cleaning mechanism and the settling tank body, the lifting and rotating mechanism is arranged between the sealing tank body and the cleaning mechanism, and the lifting and rotating mechanism is connected with the sealing tank body and the cleaning mechanism in a one-to-one mode through connecting rods. Maintenance and inspection are convenient, the daily maintenance process is greatly simplified, the working efficiency is improved, meanwhile, the mechanical damage risk possibly caused by frequent disassembly and assembly is reduced, and the service life of equipment is prolonged.
Owner:YAZHOU BAY INNOVATION RESEARCH INSTITUTE HAINAN TROPICAL OCEAN UNIVERSITY

GE fusion protein containing gH Th epitope and preparation method and application thereof

The invention discloses a gE fusion protein containing a gH Th epitope and a preparation method and application thereof, and relates to the technical field of biomedicine, the fusion protein comprises a varicella-zoster virus (VZV) glycoprotein E extracellular domain (gE) and a Th epitope-containing VZV glycoprotein H extracellular domain (gH) polypeptide. The gE fusion protein can be applied to VZV vaccines, and solves the technical problems of weak immunogenicity of gE antigens and serious side reaction of vaccines in vaccines prepared in the prior art. Compared with the Xinanlietaine, the vaccine taking the gE fusion protein as the antigen has the advantages that the variety and dosage of immunopotentiators are less, the immunogenicity is better, and the clinical side reaction is lower; besides, the gE fusion protein vaccine not only can induce a gE specific CMI reaction, but also can induce a gH specific CMI reaction, so that the effectiveness of the vaccine is further improved. In short, the gE fusion protein has good clinical application potential.
Owner:YUNNAN CHANGHE BIOTECHNOLOGY CO LTD

Use of mhc-ii expression in predicting efficacy of immunotherapy for gastric cancer

The application discloses a use of MHC-II expression in prediction of curative effect of gastric cancer immunotherapy and belongs to the field of bioengineering. Specifically, the application comprises the following steps: detecting MHC-II expression in a gastric cancer biopsy sample; baking, dewaxing and gradient alcohol treating the gastric cancer biopsy sample slice; carrying out antigen repairing and blocking treatment; then adding diluted MHC Class II antibody for incubation, and then adding immunopotentiator and enhanced enzyme-labeled antibody for incubation; finally, completing immunostaining through DAB color development, staining liquid staining and counter blue treatment, mounting and observing. The MHC-II expression signal is clear and distinguishable, the staining effect is good, and through negative and positive expression interpretation and pathological remission evaluation, it is confirmed that the MHC-II expression is significantly related to pathological remission of a gastric cancer patient and plays an important role in prediction of curative effect of gastric cancer immunotherapy.
Owner:ZHEJIANG CANCER HOSPITAL

Application of chitosan oligosaccharide in aquatic feed additive and feed

The invention belongs to the technical field of aquaculture, and discloses application of chitosan oligosaccharide in preparation of fish feed for promoting fish growth and improving disease resistance of grass carp bodies. Chitosan oligosaccharide is found to be capable of promoting fish growth and improving the disease resistance of grass carp bodies. In the embodiment, chitosan oligosaccharide is added as an immunopotentiator, so that non-specific antioxidant enzyme expression of the liver of the grass carp can be effectively induced, and the autoimmunity of the grass carp is improved. The chitosan oligosaccharide can improve the intestinal flora structure of the grass carp. In the embodiment, the relative abundance of the clostridium of the 3% chitosan oligosaccharide addition group is remarkably higher than that of the control group, and the 3% chitosan oligosaccharide addition group is the most important bacterial genus of the clostridium, so that the chitosan oligosaccharide has a remarkable effect on improving the intestinal flora structure of the grass carp.
Owner:TIANJIN AGRICULTURE COLLEGE

Compositions comprising metal-complexed plant compounds and uses thereof

The invention is directed to compositions that include metal-complexed plant compounds. The compositions can be derived from liquid concentrates, extracts, and pomace from plants, such as fruits or vegetables. The compositions can further include additional nutraceutical antimicrobials, antioxidants, and immune boosters. The compositions can be administered to animals to increase animal health, reduce stress, reduce oxidative stress, maintain health, improve health, improve immunity, improve vaccination efficacy, increase feed conversion rate, decrease pro-inflammatory cytokine levels, increase anti-inflammatory cytokines, or any combination thereof in an animal. The compositions of the invention exhibit enhanced bioavailability relative to control compositions that do not contain the metal-complexed compounds
Owner:RD LIFE SCIENCES LLC

Immunogenic composition containing gE virus-like nanoparticles as well as preparation method and application of immunogenic composition

The invention discloses an immunogenic composition containing gE virus-like nanoparticles as well as a preparation method and application of the immunogenic composition. The immunogenic composition comprises gE virus-like nanoparticles, an immunopotentiator, namely, saponin QS-21, and a neutral liposome, the gE virus-like nanoparticles comprise VZV gE, a linker peptide (SGS) and a VZV gI polypeptide containing a Th epitope. The immunogenic composition provided by the invention can be applied to VZV vaccines, and solves the technical problems of weak gE immunogenicity and serious vaccine side reaction in vaccines prepared in the prior art. The immunogenicity of the vaccine is better than that of Xinanliei, the use of an immunopotentiator is reduced, and the clinical side reaction is lower. In addition, the vaccine can also induce an obvious gI specific antibody, which is beneficial for further improving the effectiveness of the vaccine. In short, the immunogenic composition provided by the invention has good clinical application potential.
Owner:YUNNAN CHANGHE BIOTECHNOLOGY CO LTD